| Authors: |
Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, 6N106, Bethesda, MD, 20892, USA. ramya.ramaswami@nih.gov., Nordwall JA; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA., Gilbert D; MRC Clinical Trials Unit at University College London, London, UK., Kitchell E; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern, Dallas, TX, USA., Timiryasova A; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, and Department of Clinical Medicine, Copenhagen, Denmark., Mitsuyasu R; University of California Los Angeles Clinical AIDS Research and Education Center, Los Angeles, CA, USA., Phillips AN; Institute for Global Health, University College London, London, UK., Lundgren J; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, and Department of Clinical Medicine, Copenhagen, Denmark., Grabar S; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Santé Publique, AP-HP, Hôpital St Antoine, Paris, 75012, France. |
